Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 019525/0935 | |
| Pages: | 3 |
| | Recorded: | 07/06/2007 | | |
| Attorney Dkt #: | REG-07-1066 (360563-8) |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGEES' STREET ADDRESSES PREVIOUSLY RECORDED ON REEL 019492 FRAME 0297. ASSIGNOR(S) HEREBY CONFIRMS THE THAT GENOME EXPRESS' STREET ADDRESS SHOULD BE "11, CHEMIN DES PRES" AND INSERM'S STREET ADDRESS SHOULD BE "101, RUE DE TOLBIAC". |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11663127
|
Filing Dt:
|
06/28/2007
|
|
Publication #:
|
|
Pub Dt:
|
11/15/2007
| | | | |
|
Title:
|
Phosphorylated Vimentin Serving as a Marker of the Aggressiveness and/or Invasiveness of Tumors
|
|
|
Assignees
|
|
|
|
|
| 11, CHEMIN DES PRES |
| MEYLAN, FRANCE 38240 |
|
|
|
|
|
| 101, RUE DE TOLBIAC |
| PARIS, FRANCE 75013 |
|
|
Correspondence name and address
|
| |
DLA PIPER US LLP
|
| |
1650 MARKET STREET, SUITE 4900
|
| |
IP GROUP - T. DANIEL CHRISTENBURY
|
| |
PHILADELPHIA, PA 19103
|
Search Results as of:
05/30/2024 11:25 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
